Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
Josanne S de MaarMarianne LuyendijkBritt B M SuelmannDave E W van der KruijssenSjoerd G EliasSabine SieslingElsken van der WallPublished in: Breast cancer research and treatment (2023)
Differences in clinicopathological characteristics and survival between de novo and metachronous metastatic breast cancer highlight that these are distinct patients groups.